ArticleSchizophrenia bulletin2026
More Severe Brain Network Hierarchy Disorganization in Treatment-Naive Deficit Compared to Non-deficit Schizophrenia and Underlying Neurotransmitter Associations.
Article in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Disrupted hierarchical functional brain organization in affective and psychotic disorders: insights from functional brain gradients.Translational psychiatry · 2026Article
- Abnormal cortical topographic patterns associated with auditory verbal hallucination in first-episode schizophrenia.Translational psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
background and hypothesisDeficit schizophrenia (DS) represents a distinct entity characterized by primary and enduring negative symptoms, yet the neurobiological differences between DS and non-DS (NDS) remain undetermined. Using a gradient-based approach, we hypothesize that DS and NDS will exhibit convergent and divergent brain functional hierarchy patterns, each with a specific underlying neurotransmitter architecture. STUDY
designResting-state functional magnetic resonance imaging images were acquired from 44 treatment-naive DS, 55 treatment-naive NDS, and 60 matched healthy controls (HCs). Gradient metrics were calculated using the BrainSpace toolbox. The spatial correlation between gradient abnormalities in DS or NDS and density maps of 10 neurotransmitters derived by the JuSpace toolbox was analyzed to link the neuroimaging to underlying neurotransmitter information. STUDY
resultsBoth DS and NDS exhibited compressed gradient patterns compared to HC, suggesting reduced network differentiation, with more severe disorganization in DS. The ventral attention network was associated with depression symptoms in DS, whereas the visual network was related to total, general, and paranoid symptom scores in NDS. Moreover, spatial correlation of neurotransmitter analysis revealed that the gradient alterations of DS were primarily related to the serotonergic system while those of NDS were predominantly associated with the dopamine system.
conclusionsThe study suggests that independent from the potential effects of antipsychotic medication, DS and NDS are characterized by different neuropathology in brain hierarchy patterns, potentially linked to neurochemical metabolic distinction. Our findings support the hypothesis that DS is a distinct subtype versus NDS from neurodevelopmental perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.